Data Standards for Tobacco Research and Scientific Review Phase 2

Summary

The Food and Drug Administration (HHS-FDA) is forecasting a Phase 2 effort related to data standards for tobacco research and scientific review. This opportunity builds on a prior phase and is expected to involve the development, refinement, or implementation of data standards to support FDA's tobacco-related research and regulatory scientific review functions. The opportunity was forecasted as of May 2023 and full details have not yet been released.

Risks & flags

• Forecasted opportunity only — no full solicitation text available, making it impossible to assess scope specificity or wiring for an incumbent
• Phase 2 designation implies an incumbent or prior awardee from Phase 1 likely exists, which may advantage that vendor in a follow-on competition